Analysis of physical characteristics and the effectiveness of rehabilitation of elderly patients with Parkinson's disease

Analysis of clinical characteristics and rehabilitation effectiveness of Parkinson's disease in the elderly in Japan - Analysis of physical characteristics and the effectiveness of rehabilitation of elderly patients with Parkinson's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056042

Enrollment

140

Registered

2024-11-05

Start date

2024-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) diagnosis of PD has been diagnosed by two expert neurologist based on the UK Parkinsons Disease Society Brain Bank criteria, (2) Hoehn and Yahr (H&Y) stage 2-4, and (3) over 65 years of age.

Exclusion criteria

Exclusion criteria: (1) cerebrovascular disease or other complications affecting movement; (2) severe or unstable medical comorbid diseases; (3) suspected drug-induced parkinsonism due to dopamine receptor blocking agents, vascular parkinsonism, and atypical parkinsonism, such as progressive supranuclear palsy, multiple system atrophy, or corticobasal degeneration; and (4) Patients who experienced cognitive impairment within 1 year after the onset of PD.

Design outcomes

Primary

Measure	Time frame
Demographic data sex, age, age at onset, disease duration, H&Y stage, body mass index (BMI), Skeletal Muscle Index (SMI), blood test results, number of drugs (excluding anti-parkinsonian drugs), and anti-parkinsonian drugs), and motor and non-motor symptoms from the database of our institution. Outcome measures Unified Parkinson's Disease Rating Scale (UPDRS) Montreal Cognitive Assessment-Japanese (MoCA-J) Berg Balance Scale (BBS) 10-Meter Walking Test (10 MWT) Functional Independence Measure (FIM).	—

Measure

Time frame

Demographic data sex, age, age at onset, disease duration, H&Y stage, body mass index (BMI), Skeletal Muscle Index (SMI), blood test results, number of drugs (excluding anti-parkinsonian drugs), and anti-parkinsonian drugs), and motor and non-motor symptoms from the database of our institution. Outcome measures Unified Parkinson's Disease Rating Scale (UPDRS) Montreal Cognitive Assessment-Japanese (MoCA-J) Berg Balance Scale (BBS) 10-Meter Walking Test (10 MWT) Functional Independence Measure (FIM).

—

Countries

Japan

Contacts

Public ContactToshiya Shimamoto

Kumamoto southern regional hospital Department of Rehabilitation

sentyoukansetu@icloud.com0964-28-2555

Outcome results